Avalo Therapeutics (C6K0.F) Q2 2024 Earnings

May 13Confirmed
Q2 2024
-130.63
-87.45
-44.27
-1.09

Details

Expected EPS
-1.0932464
Actual EPS
-130.63368
Surprise EPS
-129.54
Surprise Percent
-11,849.15%

Description

⁨Avalo Therapeutics⁩ (⁦C6K0.F⁩) has reported earnings of ⁦-130.63368⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts